Recent insider selling at Avnet, especially at prices below current share price, signals negativity. The absence of insider buying in the past year and low insider ownership suggest a misalignment between management and smaller shareholders, making us wary of the stock.
Despite Avnet's current undervaluation, the negative profit outlook introduces a high level of uncertainty and risk. Investors are advised to consider these factors before deciding to increase their portfolio exposure to Avnet or diversify into another stock.
Given Avnet's bleak earnings forecast, its low P/E ratio appears justified as the potential for earnings improvement is not viewed by investors as strong enough to demand a higher ratio. Without better conditions, there might be obstacles to share price growth.
Insider selling at Avnet without recent insider buying could be worrying for potential investors. Investigate carefully as earnings grow, but lacking substantial ownership and demonstrating insider selling.
Avnet's cheaper price could allure investors, but the negative profit outlook and high beta escalates the investment risk. Its high future uncertainty raises the stakes of the investment.
Upgrades •$美國超微公司(AMD.US)$: BMO Capital Upgrades to Outperform from Market Perform - PT $115 (from $100) •$安諾電子(APH.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $83 •$CDW Corp(CDW.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $200 (from $205) •$好市多(COST.US)$: Deutsche Bank Upgrades to Buy from Hold - PT $579 (from $525) •$新東方(EDU.US)$: CICC Upgrades to Outperform from M...
安富利股票討論區
專欄Top upgrades and downgrades on 7/14: TSLA, TWTR, AMD, COST and more
• $美國超微公司(AMD.US)$: BMO Capital Upgrades to Outperform from Market Perform - PT $115 (from $100)
• $安諾電子(APH.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $83
• $CDW Corp(CDW.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $200 (from $205)
• $好市多(COST.US)$: Deutsche Bank Upgrades to Buy from Hold - PT $579 (from $525)
• $新東方(EDU.US)$ : CICC Upgrades to Outperform from M...
專欄Today's pre-market stock movers: BBIO, LZB, ORA, DOW and more
• $La-Z-Boy(LZB.US)$ +9.3% (In reaction to earnings/guidance)
• $Enanta Pharmaceuticals(ENTA.US)$ +6.7% (ENTA files patent infringement lawsuit against $輝瑞(PFE.US)$)
• $Ikena Oncology(IKNA.US)$ +6.6% (granted Fast Track designation for IK-930)
• $BridgeBio Pharma(BBIO.US)$ +6.4% (Announces Early Positive Data for BBP-812)
• $Krystal Biotech(KRYS.US)$ +5% (submits Biologies License Application to FDA seeking approval of B-V...
專欄Today's pre-market stock movers: FB, QCOM, PYPL, BIDU and more
• $Gol Intelligent Airlines(GOL.US)$ +18.5% (earnings report)
• $LendingClub(LC.US)$ +16.9% (earnings report)
• $MaxLinear(MXL.US)$ +15.9% (earnings report)
• $Meta Platforms(FB.US)$ +15.8% (Facebook revenue slows but user gains boost stock)
• $Noodles & Co(NDLS.US)$ +15.2% (earnings report)
• $安富利(AVT.US)$ +11.2% (earnings report)
• $高通(QCOM.US)$ +6.8% (Qualcomm reports earnings as smartphone market weakens)
• $淡水河谷(VALE.US)$ +5.3% (an...
暫無評論